13.01
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
126.67%
17.25
|
7.608 | 8.699 | 9.175 | 83.75 |
|
|
15.25%
73.71
|
63.96 | 61.46 | 58.98 | 60.78 |
| Benefits Costs and Expenses |
14.59%
70.42
|
61.46 | 59.17 | 56.05 | 54.49 |
| Costs And Expenses |
1.96%
62.71
|
63.96 | 59.17 | 56.05 | 47.39 |
| Operating Income/Loss |
0.20%
-56.47
|
-56.35 | -52.76 | -49.80 | 22.97 |
| Nonoperating Income/Loss |
31.47%
3.288
|
2.501 | 2.29 | 2.926 | 6.286 |
| Income/Loss From Continuing Operations Before Tax |
1.25%
-53.18
|
-53.85 | -50.47 | -46.88 | 29.25 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.25%
-53.18
|
-53.85 | -50.47 | -46.88 | 29.25 |
|
|
1.25%
-53.18
|
-53.85 | -50.47 | -46.88 | 29.25 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.69%
3.8763
|
167.74 | 163.99 | 162.53 | 7.8069 |
| Diluted Average Shares |
97.69%
3.8763
|
167.74 | 163.99 | 162.53 | 7.8069 |
| Basic Earnings Per Share |
9.38%
-0.29
|
-0.32 | -0.31 | -0.29 | 0.27 |
| Diluted Earnings Per Share |
9.38%
-0.29
|
-0.32 | -0.31 | -0.29 | 0.27 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):